한글목차

세계의 인슐린 펜 바늘 시장 규모는 2024년에 11억 7,800만 달러로 추정되며, 2025년부터 2031년까지 예측 기간 동안 CAGR 6.6%로 성장하여 2031년까지 17억 9,900만 달러로 확대될 것으로 예측됩니다.

본 보고서는 인슐린 펜 바늘에 대한 최근 관세 조정과 국제적인 전략적 대응 조치에 대해 국경 간 산업 발자국, 자본 배분 패턴, 지역 경제의 상호의존성, 공급망 재구성 등의 관점에서 종합적인 평가를 제공합니다.

인슐린 펜 바늘은 주사 펜과 함께 사용되며, 주사제를 체내에 투여하기 위해 사용됩니다. 인슐린 펜 바늘은 플라스틱 허브에 내장된 속이 빈 바늘로 구성되어 있으며, 주사 펜에 부착됩니다. 펜니들은 다양한 바늘 길이와 직경이 있으며, 의료진과 환자 모두 다양한 약물을 주사할 때 사용합니다. 특히 하루에 여러 번 인슐린 주사를 맞아야 하는 당뇨병 환자에게 널리 사용되며, 하루에 여러 번 인슐린 주사를 맞아야 하는 사람들에게 필수적입니다. 2024년 세계 인슐린 펜니들 생산량은 약 9,973만 개, 세계 평균 시장 가격은 1,000개당 약 118.1달러에 달했습니다.

세계 인슐린 펜 바늘 시장의 주요 성장 요인은 고령화, 운동 부족 생활 습관, 건강에 해로운 식습관으로 인한 당뇨병 환자의 증가입니다. 인슐린 요법이 당뇨병 관리의 근간을 이루는 가운데, 사용자 친화적이고 통증이 적으며 보다 정확한 투약 방법인 인슐린 펜 바늘에 대한 수요는 계속 증가하고 있습니다. 기술의 발전으로 환자의 편안함과 순응도를 향상시키는 초소형, 초소형 바늘이 개발되고 있습니다. 또한, 당뇨병 관리에 대한 인식 개선, 가정 내 인슐린 자가 투여로의 전환, 개발도상국의 의료 인프라 확충 등이 시장 성장을 더욱 촉진하고 있습니다.

성장 잠재력이 있는 것,인슐린 펜 바늘 시장은 몇 가지 도전에 직면해 있습니다. 주요 관심사 중 하나는 브랜드 바늘의 높은 비용입니다. 이는 저소득층 환자의 접근을 제한하고, 일회용 바늘의 재사용을 초래할 수 있으며, 건강상의 위험을 초래할 수 있습니다. 또한, 선진국의 시장 포화 상태와 제네릭 대체품의 가격 압력으로 인해 기존 업체 간 경쟁이 심화되고 있습니다. 안전성, 무균성, 생체적합성에 대한 규제 요건도 신규 진입자에게는 진입장벽으로 작용하고 있습니다. 마지막으로, 환자 교육과 치료 순응도는 여전히 중요한 과제입니다. 부적절한 주사 기술이나 바늘의 재사용은 치료 결과를 손상시킬 수 있기 때문입니다.

이 보고서는 인슐린 펜 바늘 세계 시장에 대해 총 판매량, 매출액, 가격, 주요 기업의 시장 점유율 및 순위에 초점을 맞추고 지역/국가, 유형 및 용도별 분석을 종합적으로 제시하는 것을 목표로 합니다.

인슐린 펜 바늘의 시장 규모, 추정 및 예측은 판매량(백만 단위) 및 매출액(백만 달러)으로 제시되며, 2024년을 기준 연도로, 2020년에서 2031년까지의 과거 데이터와 예측 데이터를 포함합니다. 정량적, 정성적 분석을 통해 독자들이 인슐린 펜 바늘 관련 사업/성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 자사 포지셔닝 분석, 정보에 입각한 사업적 판단을 할 수 있도록 지원합니다.

시장 세분화

기업별

• Embecta
• MTD Group
• Novo Nordisk
• B. Braun
• Terumo
• Owen Mumford
• Beipu Medical
• KDL Medical
• Ulticare
• Puang Medical
• Tianjin Huahong Medical
• Anhui Hongyu Wuzhou Medical
• Jiangxi Hongda Medical
• Suzhou Sali Medical
• Jiangsu Jichun Medical

유형별 부문

• 표준 인슐린 펜 바늘
• 안전형 인슐린 펜 바늘

용도별 부문

• 가정용
• 의료기관
• 기타

지역별

• 북미
  • 미국
  • 캐나다
• 아시아태평양
  • 중국
  • 일본
  • 한국
  • 동남아시아
  • 인도
  • 호주
  • 기타 아시아태평양
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 네덜란드
  • 북유럽 국가
  • 기타 유럽
• 라틴아메리카
  • 멕시코
  • 브라질
  • 기타 라틴아메리카
• 중동 및 아프리카
  • 튀르키예
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동 및 아프리카

영문목차

The global market for Insulin Pen Needles was estimated to be worth US$ 1178 million in 2024 and is forecast to a readjusted size of US$ 1799 million by 2031 with a CAGR of 6.6% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Insulin Pen Needles cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Insulin Pen needles are used in conjunction with injection pens to deliver injectable medications into the body. An insulin pen needle consists of a hollow needle which is embedded in a plastic hub and attaches to injection pens. Pen needles come in a variety of needle lengths and diameters and are used by both health professionals and patients for injection of a variety of medications. They are commonly used by people with diabetes who often require multiple daily insulin injections.In 2024, global Insulin Pen needles production reached approximately 9973 m units, with an average global market price of around US$ 118.1 per k unit.

The global insulin pen needle market is primarily driven by the rising prevalence of diabetes, fueled by aging populations, sedentary lifestyles, and unhealthy dietary habits. As insulin therapy remains a cornerstone of diabetes management, the demand for user-friendly, less painful, and more precise delivery methods like insulin pen needles continues to grow. Technological advancements have led to the development of ultra-thin, shorter needles that improve patient comfort and compliance. Additionally, increased awareness of diabetes management, the shift toward self-administration of insulin at home, and the expansion of healthcare infrastructure in developing countries further support market growth.

Despite its growth potential, the insulin pen needle market faces several challenges. One major concern is the high cost of branded needles, which can limit access for patients in low-income regions and result in reuse of single-use needles-posing health risks. Furthermore, market saturation in developed countries and pricing pressures from generic alternatives create intense competition for established manufacturers. Regulatory requirements related to safety, sterility, and biocompatibility also pose entry barriers for new players. Lastly, patient education and adherence remain critical issues, as improper injection techniques or needle reuse can compromise treatment outcomes.

This report aims to provide a comprehensive presentation of the global market for Insulin Pen Needles, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Insulin Pen Needles by region & country, by Type, and by Application.

The Insulin Pen Needles market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Pen Needles.

Market Segmentation

By Company

• Embecta
• MTD Group
• Novo Nordisk
• B. Braun
• Terumo
• Owen Mumford
• Beipu Medical
• KDL Medical
• Ulticare
• Puang Medical
• Tianjin Huahong Medical
• Anhui Hongyu Wuzhou Medical
• Jiangxi Hongda Medical
• Suzhou Sali Medical
• Jiangsu Jichun Medical

Segment by Type

• Standard Insulin Pen Needles
• Safety Insulin Pen Needles

Segment by Application

• Home Use
• Medical Institutions
• Others

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Insulin Pen Needles manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Insulin Pen Needles in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Insulin Pen Needles in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Insulin Pen Needles Product Introduction
• 1.2 Global Insulin Pen Needles Market Size Forecast
  • 1.2.1 Global Insulin Pen Needles Sales Value (2020-2031)
  • 1.2.2 Global Insulin Pen Needles Sales Volume (2020-2031)
  • 1.2.3 Global Insulin Pen Needles Sales Price (2020-2031)
• 1.3 Insulin Pen Needles Market Trends & Drivers
  • 1.3.1 Insulin Pen Needles Industry Trends
  • 1.3.2 Insulin Pen Needles Market Drivers & Opportunity
  • 1.3.3 Insulin Pen Needles Market Challenges
  • 1.3.4 Insulin Pen Needles Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Insulin Pen Needles Players Revenue Ranking (2024)
• 2.2 Global Insulin Pen Needles Revenue by Company (2020-2025)
• 2.3 Global Insulin Pen Needles Players Sales Volume Ranking (2024)
• 2.4 Global Insulin Pen Needles Sales Volume by Company Players (2020-2025)
• 2.5 Global Insulin Pen Needles Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Insulin Pen Needles Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Insulin Pen Needles Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Insulin Pen Needles
• 2.9 Insulin Pen Needles Market Competitive Analysis
  • 2.9.1 Insulin Pen Needles Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Insulin Pen Needles Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Pen Needles as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Standard Insulin Pen Needles
  • 3.1.2 Safety Insulin Pen Needles
• 3.2 Global Insulin Pen Needles Sales Value by Type
  • 3.2.1 Global Insulin Pen Needles Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Insulin Pen Needles Sales Value, by Type (2020-2031)
  • 3.2.3 Global Insulin Pen Needles Sales Value, by Type (%) (2020-2031)
• 3.3 Global Insulin Pen Needles Sales Volume by Type
  • 3.3.1 Global Insulin Pen Needles Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Insulin Pen Needles Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Insulin Pen Needles Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Insulin Pen Needles Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Home Use
  • 4.1.2 Medical Institutions
  • 4.1.3 Others
• 4.2 Global Insulin Pen Needles Sales Value by Application
  • 4.2.1 Global Insulin Pen Needles Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Insulin Pen Needles Sales Value, by Application (2020-2031)
  • 4.2.3 Global Insulin Pen Needles Sales Value, by Application (%) (2020-2031)
• 4.3 Global Insulin Pen Needles Sales Volume by Application
  • 4.3.1 Global Insulin Pen Needles Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Insulin Pen Needles Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Insulin Pen Needles Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Insulin Pen Needles Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Insulin Pen Needles Sales Value by Region
  • 5.1.1 Global Insulin Pen Needles Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Insulin Pen Needles Sales Value by Region (2020-2025)
  • 5.1.3 Global Insulin Pen Needles Sales Value by Region (2026-2031)
  • 5.1.4 Global Insulin Pen Needles Sales Value by Region (%), (2020-2031)
• 5.2 Global Insulin Pen Needles Sales Volume by Region
  • 5.2.1 Global Insulin Pen Needles Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Insulin Pen Needles Sales Volume by Region (2020-2025)
  • 5.2.3 Global Insulin Pen Needles Sales Volume by Region (2026-2031)
  • 5.2.4 Global Insulin Pen Needles Sales Volume by Region (%), (2020-2031)
• 5.3 Global Insulin Pen Needles Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Insulin Pen Needles Sales Value, 2020-2031
  • 5.4.2 North America Insulin Pen Needles Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Insulin Pen Needles Sales Value, 2020-2031
  • 5.5.2 Europe Insulin Pen Needles Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Insulin Pen Needles Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Insulin Pen Needles Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Insulin Pen Needles Sales Value, 2020-2031
  • 5.7.2 South America Insulin Pen Needles Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Insulin Pen Needles Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Insulin Pen Needles Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Insulin Pen Needles Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Insulin Pen Needles Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Insulin Pen Needles Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Insulin Pen Needles Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Insulin Pen Needles Sales Value, 2020-2031
  • 6.3.2 United States Insulin Pen Needles Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Insulin Pen Needles Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Insulin Pen Needles Sales Value, 2020-2031
  • 6.4.2 Europe Insulin Pen Needles Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Insulin Pen Needles Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Insulin Pen Needles Sales Value, 2020-2031
  • 6.5.2 China Insulin Pen Needles Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Insulin Pen Needles Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Insulin Pen Needles Sales Value, 2020-2031
  • 6.6.2 Japan Insulin Pen Needles Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Insulin Pen Needles Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Insulin Pen Needles Sales Value, 2020-2031
  • 6.7.2 South Korea Insulin Pen Needles Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Insulin Pen Needles Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Insulin Pen Needles Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Insulin Pen Needles Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Insulin Pen Needles Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Insulin Pen Needles Sales Value, 2020-2031
  • 6.9.2 India Insulin Pen Needles Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Insulin Pen Needles Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Embecta
  • 7.1.1 Embecta Company Information
  • 7.1.2 Embecta Introduction and Business Overview
  • 7.1.3 Embecta Insulin Pen Needles Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Embecta Insulin Pen Needles Product Offerings
  • 7.1.5 Embecta Recent Development
• 7.2 MTD Group
  • 7.2.1 MTD Group Company Information
  • 7.2.2 MTD Group Introduction and Business Overview
  • 7.2.3 MTD Group Insulin Pen Needles Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 MTD Group Insulin Pen Needles Product Offerings
  • 7.2.5 MTD Group Recent Development
• 7.3 Novo Nordisk
  • 7.3.1 Novo Nordisk Company Information
  • 7.3.2 Novo Nordisk Introduction and Business Overview
  • 7.3.3 Novo Nordisk Insulin Pen Needles Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Novo Nordisk Insulin Pen Needles Product Offerings
  • 7.3.5 Novo Nordisk Recent Development
• 7.4 B. Braun
  • 7.4.1 B. Braun Company Information
  • 7.4.2 B. Braun Introduction and Business Overview
  • 7.4.3 B. Braun Insulin Pen Needles Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 B. Braun Insulin Pen Needles Product Offerings
  • 7.4.5 B. Braun Recent Development
• 7.5 Terumo
  • 7.5.1 Terumo Company Information
  • 7.5.2 Terumo Introduction and Business Overview
  • 7.5.3 Terumo Insulin Pen Needles Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Terumo Insulin Pen Needles Product Offerings
  • 7.5.5 Terumo Recent Development
• 7.6 Owen Mumford
  • 7.6.1 Owen Mumford Company Information
  • 7.6.2 Owen Mumford Introduction and Business Overview
  • 7.6.3 Owen Mumford Insulin Pen Needles Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Owen Mumford Insulin Pen Needles Product Offerings
  • 7.6.5 Owen Mumford Recent Development
• 7.7 Beipu Medical
  • 7.7.1 Beipu Medical Company Information
  • 7.7.2 Beipu Medical Introduction and Business Overview
  • 7.7.3 Beipu Medical Insulin Pen Needles Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Beipu Medical Insulin Pen Needles Product Offerings
  • 7.7.5 Beipu Medical Recent Development
• 7.8 KDL Medical
  • 7.8.1 KDL Medical Company Information
  • 7.8.2 KDL Medical Introduction and Business Overview
  • 7.8.3 KDL Medical Insulin Pen Needles Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 KDL Medical Insulin Pen Needles Product Offerings
  • 7.8.5 KDL Medical Recent Development
• 7.9 Ulticare
  • 7.9.1 Ulticare Company Information
  • 7.9.2 Ulticare Introduction and Business Overview
  • 7.9.3 Ulticare Insulin Pen Needles Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Ulticare Insulin Pen Needles Product Offerings
  • 7.9.5 Ulticare Recent Development
• 7.10 Puang Medical
  • 7.10.1 Puang Medical Company Information
  • 7.10.2 Puang Medical Introduction and Business Overview
  • 7.10.3 Puang Medical Insulin Pen Needles Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Puang Medical Insulin Pen Needles Product Offerings
  • 7.10.5 Puang Medical Recent Development
• 7.11 Tianjin Huahong Medical
  • 7.11.1 Tianjin Huahong Medical Company Information
  • 7.11.2 Tianjin Huahong Medical Introduction and Business Overview
  • 7.11.3 Tianjin Huahong Medical Insulin Pen Needles Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 Tianjin Huahong Medical Insulin Pen Needles Product Offerings
  • 7.11.5 Tianjin Huahong Medical Recent Development
• 7.12 Anhui Hongyu Wuzhou Medical
  • 7.12.1 Anhui Hongyu Wuzhou Medical Company Information
  • 7.12.2 Anhui Hongyu Wuzhou Medical Introduction and Business Overview
  • 7.12.3 Anhui Hongyu Wuzhou Medical Insulin Pen Needles Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.12.4 Anhui Hongyu Wuzhou Medical Insulin Pen Needles Product Offerings
  • 7.12.5 Anhui Hongyu Wuzhou Medical Recent Development
• 7.13 Jiangxi Hongda Medical
  • 7.13.1 Jiangxi Hongda Medical Company Information
  • 7.13.2 Jiangxi Hongda Medical Introduction and Business Overview
  • 7.13.3 Jiangxi Hongda Medical Insulin Pen Needles Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.13.4 Jiangxi Hongda Medical Insulin Pen Needles Product Offerings
  • 7.13.5 Jiangxi Hongda Medical Recent Development
• 7.14 Suzhou Sali Medical
  • 7.14.1 Suzhou Sali Medical Company Information
  • 7.14.2 Suzhou Sali Medical Introduction and Business Overview
  • 7.14.3 Suzhou Sali Medical Insulin Pen Needles Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.14.4 Suzhou Sali Medical Insulin Pen Needles Product Offerings
  • 7.14.5 Suzhou Sali Medical Recent Development
• 7.15 Jiangsu Jichun Medical
  • 7.15.1 Jiangsu Jichun Medical Company Information
  • 7.15.2 Jiangsu Jichun Medical Introduction and Business Overview
  • 7.15.3 Jiangsu Jichun Medical Insulin Pen Needles Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.15.4 Jiangsu Jichun Medical Insulin Pen Needles Product Offerings
  • 7.15.5 Jiangsu Jichun Medical Recent Development

8 Industry Chain Analysis

• 8.1 Insulin Pen Needles Industrial Chain
• 8.2 Insulin Pen Needles Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Insulin Pen Needles Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Insulin Pen Needles Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer